Answers are grounded in this paper and cite their sources.
At the European Medicines Agency, the aging of the population has prompted an analysis of whether the regulatory system is adapted to taking the needs of older people into account in the development, approval, and use of medications.
No takes yet. Share an insight, caveat, or question.
Cerreta et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: